Clinical Trials on INI1-negative Tumors
Total 20294 results
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
Keystone Nano, IncNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedCarcinoma | Cancer | Solid Tumors | TumorUnited States
-
Fujian Cosunter Pharmaceutical Co. LtdUnknownSolid Tumor | C-Met Mutation-Related TumorsChina
-
AbbVieActive, not recruitingCancer | Advanced Solid Tumors | Metastatic Solid Tumors | Triple-Negative Breast Cancer (TNBC) | Non-small-cell-lung-cancer (NSCLC)United States, Australia, France, Israel, Spain, Taiwan
-
NBE-Therapeutics AGCmed Clinical ServicesTerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Samsung Medical CenterRecruitingTriple Negative Breast Cancer | Pembrolizumab | Neoadjuvant Chemotherapy | Tumor MicroenvironmentKorea, Republic of
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Australia
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Puerto Rico
-
Universitätsklinikum Hamburg-EppendorfCompletedBrain and Central Nervous System TumorsGermany
-
Children's Hospital Los AngelesNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
CytosinLab Therapeutics Co., Ltd.RecruitingPancreatic Cancer | Non-small Cell Lung Cancer | Solid Tumors | Triple-negative Breast CancerChina
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteCompletedNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden...Active, not recruitingNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting | Neuroendocrine Tumor, MalignantUnited States
-
Curis, Inc.CompletedHigh-grade Serous Ovarian Cancer | Solid Tumors | Triple-Negative Breast Cancer | NUT Midline CarcinomaUnited States
-
Kathy MillerPfizer; Astex Pharmaceuticals, Inc.; Van Andel Institute Stand Up to Cancer TeamCompletedMetastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Yusuf MendaNational Cancer Institute (NCI); Holden Comprehensive Cancer Center; Perspective...Enrolling by invitationNeuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
Seattle Children's HospitalActive, not recruitingGlioma | Ependymoma | Medulloblastoma | Pineoblastoma | Central Nervous System Tumor, Pediatric | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus CarcinomaUnited States
-
Seattle Children's HospitalActive, not recruitingGlioma | Ependymoma | Medulloblastoma | Pineoblastoma | Central Nervous System Tumor, Pediatric | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus CarcinomaUnited States
-
Institut CurieActive, not recruitingTriple Negative Breast Cancer | Pediatric Cancer | Metastatic Uveal Melanoma | Luminal B Breast CancerFrance
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
University of IowaNovartisNot yet recruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
Peregrine PharmaceuticalsWithdrawnBreast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
-
pharmaand GmbHGilead SciencesTerminatedOvarian Cancer | Solid Tumor | Urothelial Carcinoma | Triple-negative Breast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Gastroenteropancreatic Neuroendocrine TumorChina
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
University Hospital, ToursInstitut Cancerologie de l'OuestTerminatedMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor | HER-2 Negative TumorFrance
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced Gastroenteropancreatic Neuroendocrine Tumor
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Extragonadal Germ Cell Tumor | Pediatric Germ Cell TumorUnited States
-
Peter AndersonCompletedMetastatic Neuroendocrine Tumor | Recurrent Neuroendocrine TumorUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Institute of Cancer Research, United Kingdom; National...Completed
-
Burzynski Research InstituteTerminatedPrimitive Neuroectodermal TumorUnited States
-
Weill Medical College of Cornell UniversityRecruitingCentral Nervous System Tumor | Pediatric Central Nervous System TumorUnited States
-
Molecular Insight Pharmaceuticals, Inc.Withdrawn
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedEpithelial Odontogenic TumoursFrance
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | NeuroblastomaUnited States
-
Giselle ShollerK C Pharmaceuticals Inc.; USWM, LLCAvailableEmbryonal Tumor With Abundant Neuropil and True Rosettes | Medulloblastoma | Neuroblastoma | Medulloepithelioma | Ependymoblastoma | Typical Teratoid Rhabdoid TumorUnited States
-
Arcispedale Santa Maria Nuova-IRCCSCompletedNeuroendocrine TumoursAustria, Italy
-
Societe Internationale d'Oncologie PediatriqueCompletedBrain and Central Nervous System TumorsUnited Kingdom
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedBrain Tumor | Head and Neck Tumor | Skull Base TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMedulloblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Anaplastic Medulloblastoma | Supratentorial Embryonal Tumor, Not Otherwise SpecifiedUnited States, Canada, Australia, Puerto Rico
-
Prof. Wolfgang JanniCompletedHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
Fudan UniversityTongji Hospital; Qilu Hospital of Shandong University; Tianjin Medical University... and other collaboratorsNot yet recruitingPancreatic Neuroendocrine Tumor | Solid Pseudopapillary Tumor of the Pancreas | Pancreatic Tumor, Benign
-
Francesco De CobelliCompleted
-
IpsenTerminatedNeuroendocrine TumoursUnited Kingdom, France, Germany, Australia, Italy
-
IpsenCompletedGastro-Enteropancreatic Neuroendocrine TumorUnited States, Austria, Denmark